United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for Calcitonin

Author:

Kahaly George J1,Algeciras-Schimnich Alicia2,Davis Thomas E3,Diana Tanja1,Feldkamp Joachim4,Karger Stefan5,König Jochem6,Lupo Mark A7,Raue Friedhelm8,Ringel Matthew D9,Sipos Jennifer A9,Kratzsch Juergen10

Affiliation:

1. Molecular Thyroid Research Laboratory, Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany

2. Mayo Clinic, Rochester, MN

3. Indiana University School of Medicine, Indianapolis, IN

4. City Hospital, Bielefeld, Germany

5. Clinic for Endocrinology and Nephrology, Leipzig University, Germany

6. Institute of Medical Biostatistics, Epidemiology and Informatics, JGU Medical Center, Mainz, Germany

7. Thyroid & Endocrine Center of Florida, Sarasota, FL

8. Endocrine Practice, Heidelberg, Germany

9. The Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center, Columbus, OH

10. Institute for Clinical Chemistry, Leipzig University, Germany

Abstract

Abstract BACKGROUND The objective of this study is the validation and proof of clinical relevance of a novel electrochemiluminescence immunoassay (ECLIA) for the determination of serum calcitonin (CT) in patients with medullary thyroid carcinoma (MTC) and in different diseases of the thyroid and of calcium homeostasis. METHODS This was a multicenter prospective study on basal serum CT concentrations performed in 9 US and European referral institutions. In addition, stimulated CT concentrations were measured in 50 healthy volunteers after intravenous calcium administration (2.5 mg/kg bodyweight). RESULTS In total, 1929 patients and healthy controls were included. Limits of blank, detection, and quantification for the ECLIA were 0.3, 0.5, and 1 ng/L, respectively. Highest intra- and interassay coefficients of variation were 7.4% (CT concentration, 0.8 ng/L) and 7.0% (1.1 ng/L), respectively. Medians (interval) of serum CT concentrations in 783 healthy controls were 0.8 ng/L (<0.5–12.7) and 3 ng/L (<0.5–18) for females and males, respectively (97.5th percentile, 6.8 and 11.6 ng/L, respectively). Diagnostic sensitivity and specificity were 100%/97.1% and 96.2%/96.4%, for female/males, respectively. Patients (male/female) with primary hyperparathyroidism, renal failure, and neuroendocrine tumors showed CT concentrations >97.5th percentile in 33%/4.7%, 18.5%/10%, and 8.3%/12%, females/males, respectively. Peak serum CT concentrations were reached 2 min after calcium administration (161.7 and 111.8 ng/L in males and females, respectively; P < 0.001). CONCLUSIONS Excellent analytical performance, low interindividual variability, and low impact of confounders for increased CT concentrations in non-MTC patients indicate that the investigated assay has appropriate clinical utility. Calcium-stimulated CT results suggest good test applicability owing to low interindividual variability.

Funder

Study grant to the JGU Medical Center from Roche Diagnostics

Indiana University

Roche

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Critically evaluated key points on hereditary medullary thyroid carcinoma;Frontiers in Endocrinology;2024-06-11

2. Schilddrüse (peripher);Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel;2024

3. Medullary thyroid cancer - An update;Best Practice & Research Clinical Endocrinology & Metabolism;2023-01

4. Medullary thyroid carcinoma in children: current state of the art and future perspectives;Journal of Pediatric Endocrinology and Metabolism;2021-10-01

5. Comparison of Three Automated Calcitonin Immunoassays for Evaluating the Equivalence Near the Clinical Decision Point;Laboratory Medicine Online;2021-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3